Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Telomir Pharmaceuticals, Inc.

Clinical trials sponsored by Telomir Pharmaceuticals, Inc., explained in plain language.

Telomir Pharmaceuticals, Inc. TELO NASDAQ

Develops drugs targeting telomerase for cancer and age-related diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1

New pill takes on tough breast cancer in first human trial

Disease control Not yet recruiting

This early-phase trial tests an oral drug called Zn-Telomir in 76 adults with advanced or metastatic triple-negative breast cancer that has worsened after prior treatments. The study has two parts: first, finding a safe dose, and second, checking if the drug shrinks tumors. It is…

Phase: PHASE1, PHASE2 • Sponsor: Telomir Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC